MBX Biosciences
IPOPrecision Therapeutics. Simplified Disease Management.
Public · Carmel · Founded 2018 · $228.1M raised
- Headquarters
- Carmel
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- mbxbio.com
- Total Funding
- $228.1M
- Last Round
- $63.5M Series CAug 2024
- Rounds
- 4
- Type
- Public
About
MBX Biosciences is pioneering Precision Endocrine Peptide (PEP) therapeutics for patients with endocrine and metabolic disorders. Its pipeline includes MBX 2109 (Phase 2, hypoparathyroidism), MBX 1416 (Phase 1, post-bariatric hypoglycemia), and pre-clinical obesity programs. The company went public on Nasdaq (MBX) in September 2024.
Summary
MBX Biosciences is a Healthcare company based in Carmel, founded in 2018. It has raised $228.1M in total across 4 rounds, most recently a $63.5M Series C round in Aug 2024. Investors include Frazier Healthcare, J.P. Morgan and Deep Track Capital.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Sep 2024
Sign up to see all 5 rounds
Seed through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Frazier Healthcare
2 rounds
J.P. Morgan
1 round
Deep Track Capital
1 round
Wellington Management
1 round
New Enterprise Associates
2 rounds
OrbiMed
2 rounds
Jefferies
1 round
Guggenheim Securities
1 round
Stifel Financial
1 round
Driehaus Capital Management
1 round
Frazier Life Sciences
1 round
Indiana Philanthropic Venture Fund
1 round
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mbx-biosciences"><img src="https://indexed.vc/api/badge/company/mbx-biosciences" alt="MBX Biosciences on Indexed.vc" width="260" height="76" /></a>